Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections

Antimicrobial Agents and Chemotherapy
Ruthy Tal-JasperDror Marchaim

Abstract

Carbapenems are considered the treatment of choice for Acinetobacter baumannii infections. Many facilities implement preventive measures toward only carbapenem-resistant A. baumannii (CRAB). However, the independent role of the carbapenem resistance determinant on patient outcomes remains controversial. In a 6-year analysis of adults with A. baumannii bloodstream infection (BSI), the outcomes of 149 CRAB isolates were compared to those of 91 patients with carbapenem-susceptible A. baumannii In bivariable analyses, CRAB BSIs were significantly associated with worse outcomes and with a delay in the initiation of appropriate antimicrobial therapy (DAAT). However, in multivariable analyses, carbapenem resistance status was no longer associated with poor outcomes, while DAAT remained an independent predictor. The epidemiological significance of A. baumannii should not be determined by its resistance to carbapenems.

References

Aug 17, 1985·British Medical Journal·J F BionI M Ledingham
Sep 21, 1963·JAMA : the Journal of the American Medical Association·S KATZM W JAFFE
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Feb 12, 2005·Emerging Infectious Diseases·Aharon AbboYehuda Carmeli
May 17, 2005·The Journal of Hospital Infection·M PaulS Pitlik
Apr 22, 2006·The Journal of Antimicrobial Chemotherapy·Matthew E FalagasPanayiota Morfou
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert A Bonomo, Dora Szabo
Jan 11, 2007·The Journal of Antimicrobial Chemotherapy·Ki Tae KwonNam Yong Lee
Aug 19, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A AbboM J Schwaber
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Jan 17, 2008·Drugs·Jacob Gilad, Yehuda Carmeli
Mar 21, 2008·The New England Journal of Medicine·L Silvia Munoz-Price, Robert A Weinstein
Jun 6, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D MarchaimM Weinberger
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Oct 29, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachMyoung Kim
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Tara ReddyKeith S Kaye
May 14, 2010·The New England Journal of Medicine·Anton Y Peleg, David C Hooper
May 28, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joel Fishbain, Anton Y Peleg
Jul 22, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Wang-Huei ShengShan-Chwen Chang
Aug 19, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L Silvia Munoz-PriceRobert A Weinstein
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Mical PaulLeonard Leibovici
Jun 21, 2011·Diagnostic Microbiology and Infectious Disease·Yehuda CarmeliMitchell J Schwaber
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
May 12, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shih-Tse HuangChang-Phone Fung
Aug 2, 2013·Future Microbiology·Christopher Bogan, Dror Marchaim
Oct 30, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rachel LatibeaudiereL Silvia Munoz-Price

❮ Previous
Next ❯

Citations

Sep 24, 2016·Infectious Disease Clinics of North America·Amos AdlerDror Marchaim
Nov 14, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kai ZhouChao Zhuo
Oct 11, 2019·Current Opinion in Infectious Diseases·Silvia CorcioneFrancesco G De Rosa
Jun 5, 2020·Current Microbiology·Gabrielle Limeira GenteluciMaria Helena Simões Villas Bôas
Aug 24, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·X ZhenH Dong
Mar 20, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Shani Zilberman-ItskovichDror Marchaim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Wichai SantimaleeworagunKevin W Garey
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Shih-Tse HuangChang-Phone Fung
Enfermedades infecciosas y microbiología clínica
Antonio Oliver
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
L Silvia Munoz-PriceRobert A Weinstein
© 2022 Meta ULC. All rights reserved